Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

258
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
258
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

335
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

1.5K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.5K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

1.2K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

893
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
893
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.3K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-like.

JHEP reports : innovation in hepatology·2026
Same author

Gender equality and equity in intensive care: an international Delphi consensus study.

Intensive care medicine·2026
Same author

Use of intracranial pressure monitoring and risk factors for the development of intracranial hypertension in acute liver failure.

Journal of hepatology·2025
Same author

Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)-2 Score: A Consensus Statement.

JAMA network open·2025
Same author

Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score.

JAMA·2025
Same author

Rapid response teams and recommended ward-based management of acute deterioration: a single-centre retrospective cohort study in an inner-city London (UK) teaching hospital.

BMJ open·2025

Video Experimental Relacionado

Updated: Apr 1, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.2K

Insuficiencia hepática aguda y crónica

William Bernal1, Rajiv Jalan2, Alberto Quaglia3

  • 1Liver Intensive Therapy Unit, King's College Hospital, London, UK.

Lancet (London, England)
|October 2, 2015
PubMed
Resumen
Este resumen es generado por máquina.

La insuficiencia hepática aguda y crónica, una afección hepática grave, presenta riesgos significativos de mortalidad. Las nuevas herramientas de diagnóstico como la puntuación de insuficiencia orgánica CLIF-C ayudan en el manejo de este complejo síndrome.

Más Videos Relacionados

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.2K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.3K

Videos de Experimentos Relacionados

Last Updated: Apr 1, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.2K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.2K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.3K

Área de la Ciencia:

  • Hepatología
  • Medicina de cuidados intensivos
  • Médico interno

Sus antecedentes:

  • La insuficiencia hepática aguda-crónica (ACLF) implica una disminución aguda de la función hepática en pacientes con enfermedad hepática crónica.
  • Esta condición se caracteriza por la insuficiencia hepática y extrahepática de los órganos, lo que lleva a una alta mortalidad a corto plazo.
  • La inflamación sistémica y la susceptibilidad a las infecciones son características fisiopatológicas clave de la LCA.

Objetivo del estudio:

  • Introducir el puntaje de insuficiencia hepática crónica (CLIF-C) para la clasificación y el pronóstico de la ACLF.
  • Destacar la necesidad de mejorar las estrategias de gestión de la FLAC debido a su alta mortalidad.
  • Para hacer hincapié en la naturaleza clínica y fisiopatológica distinta de ACLF.

Principales métodos:

  • Desarrollo y validación de la puntuación de insuficiencia orgánica CLIF-C.
  • Análisis de los datos de los pacientes para comprender las características y los resultados del ACLF.
  • Revisión de las prácticas clínicas actuales y del trasplante de hígado como intervención.

Principales resultados:

  • La puntuación de insuficiencia orgánica CLIF-C proporciona una nueva herramienta para clasificar y evaluar el pronóstico en ACLF.
  • Los precipitantes comunes incluyen infecciones y hepatitis alcohólica, aunque más del 40% de los casos carecen de un desencadenante identificado.
  • El trasplante de hígado es efectivo en casos selectos, pero se enfrenta a barreras como la disponibilidad de órganos y el momento.

Conclusiones:

  • La LCA es un síndrome distinto que requiere criterios diagnósticos y de pronóstico específicos.
  • El tratamiento eficaz implica el tratamiento de los precipitantes, la prestación de cuidados de apoyo y la consideración del trasplante de hígado.
  • El desarrollo de vías e intervenciones de manejo es crucial para reducir la mortalidad por ACLF.